Katarína Schwarzová
YOU?
Author Swipe
View article: Temporal Muscle Thickness Correlates with Functional Decline in Huntington's Disease
Temporal Muscle Thickness Correlates with Functional Decline in Huntington's Disease Open
View article: Optical coherence tomography – A possible biomarker in early huntington’s disease
Optical coherence tomography – A possible biomarker in early huntington’s disease Open
Objective To assess the role of spectral domain Optical Coherence Tomography (OCT) as a biomarker in Huntington’s disease (HD). Methods This cross-sectional study compared spectral domain OCT data, cognitive function, and olfactory functio…
View article: Silent destruction: hidden muscle wasting and body decline in early Huntington’s disease
Silent destruction: hidden muscle wasting and body decline in early Huntington’s disease Open
Huntington´s Disease (HD) is an autosomal dominant, neurodegenerative disorder with characteristic motor, behavioural, and cognitive impairment. Mutant Huntingtin may also affect peripheral tissue. We aimed to assess skeletal muscle (SMM) …
View article: CGRP-Targeted Migraine Therapies in Patients With Vascular Risk Factors or Stroke
CGRP-Targeted Migraine Therapies in Patients With Vascular Risk Factors or Stroke Open
Calcitonin gene-related peptide (CGRP)-targeted therapies, including monoclonal antibodies (mAbs) and gepants, represent a major advancement in migraine prevention, offering greater efficacy and improved tolerability compared with traditio…
View article: Serum neurofilament light chain but not serum glial fibrillary acidic protein is a marker of early Huntington’s disease
Serum neurofilament light chain but not serum glial fibrillary acidic protein is a marker of early Huntington’s disease Open
View article: Optical Coherence Tomography in Huntington's Disease—A Potential Future Biomarker for Neurodegeneration?
Optical Coherence Tomography in Huntington's Disease—A Potential Future Biomarker for Neurodegeneration? Open
Huntington's disease (HD) is a progressive neurodegenerative disorder for which, until now, only symptomatic treatment has been available. Lately, there have been multiple ongoing clinical trials targeting therapeutic agents for preventing…
View article: Olfactory dysfunction as potential biomarker in neurodegenerative diseases: a narrative review
Olfactory dysfunction as potential biomarker in neurodegenerative diseases: a narrative review Open
Neurodegenerative diseases represent a group of disorders characterized by progressive degeneration of neurons in the central nervous system, leading to a range of cognitive, motor, and sensory impairments. In recent years, there has been …
View article: Preferences regarding Disclosure of Risk for Parkinson's Disease in a Population‐based Study
Preferences regarding Disclosure of Risk for Parkinson's Disease in a Population‐based Study Open
Background Preferences for risk disclosure in population‐based studies assessing Parkinson's disease (PD) risk have not been assessed so far. Objectives To examine preferences for risk disclosure in a subset of the European Healthy Brain A…
View article: Serum Neurofilament Light and Clinical Biomarkers for Disease Staging in Huntington's Disease
Serum Neurofilament Light and Clinical Biomarkers for Disease Staging in Huntington's Disease Open
Recently, the Huntington's Disease (HD) Integrated Staging System (HD-ISS) was developed as a new framework to standardize clinical research for HD.1 Nevertheless, HD patients can show variable performance in certain tests at a particular …
View article: Initial attachment of Borrelia burgdorferi spirochetes to Vero cells
Initial attachment of Borrelia burgdorferi spirochetes to Vero cells Open
The optimal time for spirochetal adhesion in our model was 1 h postinoculation. Our results suggest that borrelia attaches to the tested cells by length and by the tip. The data showed that the extent of attachment varied between the two b…